ik-930
ikena oncology
['ik-930', '$ikna', 'ikena ']
ikena oncology shares differentiation profile of ik-930, a novel hippo-pathway inhibitor, including projected therapeutic index advantages and breadth of patient populations at aacr 2023 annual meeting $ikna 
Real-Time News, Market Data and Stock Quotes for Biotech, Pharma, and Healthcare Stocks